logo
logo

Dna Script Inks $200M Series C

Dna Script Inks $200M Series C

01/04/22, 2:59 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan francisco
Money raised
$200 million
Round Type
series c
DNA Script, a provider of enzymatic DNA synthesis for on-demand DNA printing, has raised $200 million in Series C financing.

Company Info

Company
Dna Script
Location
san francisco, california, united states
Additional Info
Founded in 2014, DNA Script is a pioneering life sciences technology company developing a new, faster, more powerful and versatile way to design and manufacture nucleic acids. The company has developed an alternative to traditional DNA synthesis called Enzymatic DNA Synthesis, or EDS, allowing this technology to be accessible to labs with the first benchtop enzymatic synthesis instrument, the SYNTAX System. By putting DNA synthesis back in the lab, DNA Script aims to transform life sciences research through innovative technology that gives researchers unprecedented control and autonomy. www.dnascript.com.